Binding of Glutathione to Enterovirus Capsids Is Essential for Virion Morphogenesis

PLoS Pathogens

Volumn 10, Issue 4, 2014, Pages

  Thibaut, Hendrik Jan ^a,b   van der Linden, Lonneke ^a,c   Jiang, Ping ^d   Thys, Bert ^e   Canela, María Dolores ^f   Aguado, Leire ^f   Rombaut, Bart ^e   Wimmer, Eckard ^d   Paul, Aniko ^d   Pérez Pérez, María Jesús ^f   van Kuppeveld, Frank J M ^b,c   Neyts, Johan ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UTRECHT UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d STONY BROOK UNIVERSITY   (United States)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BUTHIONINE SULFOXIMINE; CAPSID PROTEIN; DIMETHYL SULFOXIDE; ENVIROXIME; GELDANAMYCIN; GLUTATHIONE; GUANIDINE; METHIONINE; POLYPROTEIN; TP 219; TP219; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COXSACKIE VIRUS B3; DENSITOMETRY; ENTEROVIRUS INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; POLIOMYELITIS VIRUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS MORPHOGENESIS; VIRUS REPLICATION; VIRUS RESISTANCE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHLOROCEBUS AETHIOPS; ENTEROVIRUS; GENETICS; HELA CELL LINE; METABOLISM; MUTATION; PHYSIOLOGY; VERO CELL LINE;

ANIMALS; CAPSID; CERCOPITHECUS AETHIOPS; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; GLUTATHIONE; HELA CELLS; HUMANS; MUTATION; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION;

EID: 84901343539     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004039     Document Type: Article

References (58)

1. Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R, (2011) Enterovirus infections of the central nervous system. Virology 411: 288-305.
2. Hober D, Sauter P, (2010) Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 6: 279-289.
3. Thibaut HJ, De Palma AM, Neyts J, (2012) Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol 83: 185-192.
4. Hogle JM, (2002) Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol 56: 677-702.
5. Shingler KL, Yoder JL, Carnegie MS, Ashley RE, Makhov AM, et al. (2013) The Enterovirus 71 A-particle Forms a Gateway to Allow Genome Release: A CryoEM Study of Picornavirus Uncoating. PLoS Pathog 9: e1003240.
6. Bedard KM, Semler BL, (2004) Regulation of picornavirus gene expression. Microbes Infect 6: 702-713.
7. Rozovics JM, Semler BL, (2010) Genome Replication I: the Players. In: The Picornaviruses pp. 107-125.
8. Mueller S, Wimmer E, Cello J, (2005) Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res 111: 175-193.
9. Geller R, Vignuzzi M, Andino R, Frydman J, (2007) Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev 21: 195-205.
10. Macejak DG, Sarnow P, (1992) Association of heat shock protein 70 with enterovirus capsid precursor P1 in infected human cells. J Virol 66: 1520-1527.
11. Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL, (1988) Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 166: 265-270.
12. Ansardi DC, Porter DC, Morrow CD, (1991) Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J Virol 65: 2088-2092.
13. Ansardi DC, Porter DC, Morrow CD, (1992) Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J Virol 66: 4556-4563.
14. Goodwin S, Tuthill TJ, Arias A, Killington RA, Rowlands DJ, (2009) Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner. J Virol 83: 11275-11282.
15. Moscufo N, Simons J, Chow M, (1991) Myristoylation is important at multiple stages in poliovirus assembly. J Virol 65: 2372-2380.
16. Moscufo N, Chow M, (1992) Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions. J Virol 66: 6849-6857.
17. Vance LM, Moscufo N, Chow M, Heinz BA, (1997) Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 71: 8759-8765.
18. Li JP, Baltimore D, (1990) An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J Virol 64: 1102-1107.
19. Nugent CI, Johnson KL, Sarnow P, Kirkegaard K, (1999) Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol 73: 427-435.
20. Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, et al. (2010) Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog 6: e1001066.
21. Nugent CI, Kirkegaard K, (1995) RNA binding properties of poliovirus subviral particles. J Virol 69: 13-22.
22. Wang C, Jiang P, Sand C, Paul AV, Wimmer E, (2012) Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis. J Virol 86: 9964-9975.
23. Hindiyeh M, Li QH, Basavappa R, Hogle JM, Chow M, (1999) Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J Virol 73: 9072-9079.
24. Mikami T, Satoh N, Hatayama I, Nakane A, (2004) Buthionine sulfoximine inhibits cytopathic effect and apoptosis induced by infection with human echovirus 9. Arch Virol 149: 1117-1128.
25. Smith AD, Dawson H, (2006) Glutathione is required for efficient production of infectious picornavirus virions. Virology 353: 258-267.
26. Meister A, Anderson ME, (1983) Glutathione. Annu Rev Biochem 52: 711-760.
27. Pompella A, Visvikis A, Paolicchi A, De T, V, Casini AF, (2003) The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66: 1499-1503.
28. Fraternale A, Paoletti MF, Casabianca A, Nencioni L, Garaci E, et al. (2009) GSH and analogs in antiviral therapy. Mol Aspects Med 30: 99-110.
29. Aguado L, Thibaut HJ, Priego EM, Jimeno ML, Camarasa MJ, et al. (2010) 9-Arylpurines as a novel class of enterovirus inhibitors. J Med Chem 53: 316-324.
30. Huang ZZ, Chen C, Zeng Z, Yang H, Oh J, et al. (2001) Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. FASEB J 15: 19-21.
31. Soglia JR, Harriman SP, Zhao S, Barberia J, Cole MJ, et al. (2004) The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent. J Pharm Biomed Anal 36: 105-116.
32. Wen B, Fitch WL, (2009) Screening and characterization of reactive metabolites using glutathione ethyl ester in combination with Q-trap mass spectrometry. J Mass Spectrom 44: 90-100.
33. Ramirez-Molina C, Burton L, (2009) Screening strategy for the rapid detection of in vitro generated glutathione conjugates using high-performance liquid chromatography and low-resolution mass spectrometry in combination with LightSight software for data processing. Rapid Commun Mass Spectrom 23: 3501-3512.
34. Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, et al. (1995) The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3: 653-667.
35. Arnold E, Rossmann MG, (1990) Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A. J Mol Biol 211: 763-801.
36. Groarke JM, Pevear DC, (1999) Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. J Infect Dis 179: 1538-1541.
37. Rombaut B, Andries K, Boeye A, (1991) A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids. J Gen Virol 72 (Pt 9):: 2153-2157.
38. Pfister T, Pasamontes L, Troxler M, Egger D, Bienz K, (1992) Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells. Virology 188: 676-684.
39. Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, et al. (1989) Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J 8: 1567-1579.
40. Li C, Wang JC, Taylor MW, Zlotnick A, (2012) In vitro assembly of an empty picornavirus capsid follows a dodecahedral path. J Virol 86: 13062-13069.
41. Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, et al. (2013) Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A 110: 5463-5467.
42. Macadam AJ, Ferguson G, Arnold C, Minor PD, (1991) An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol 65: 5225-5231.
43. Pfister T, Egger D, Bienz K, (1995) Poliovirus subviral particles associated with progeny RNA in the replication complex. J Gen Virol 76 (Pt 1):: 63-71.
44. Guo HC, Sun SQ, Jin Y, Yang SL, Wei YQ, et al. (2013) Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res 44: 48. 1297-9716-44-48.
45. Martin-Belmonte F, Lopez-Guerrero JA, Carrasco L, Alonso MA, (2000) The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes. Biochemistry 39: 1083-1090.
46. Bhatnagar RS, Gordon JI, (1997) Understanding covalent modifications of proteins by lipids: where cell biology and biophysics mingle. Trends Cell Biol 7: 14-20.
47. McLaughlin S, Aderem A, (1995) The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem Sci 20: 272-276.
48. Lim SY, Raftery MJ, Goyette J, Geczy CL, (2010) S-glutathionylation regulates inflammatory activities of S100A9. J Biol Chem 285: 14377-14388.
49. Eichinger A, Nasreen A, Kim HJ, Skerra A, (2007) Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J Biol Chem 282: 31068-31075.
50. Oakley AJ, Bhatia S, Ecroyd H, Garner B, (2012) Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions: mechanism for selective oxidation of Met-93. PLoS One 7: e34057.
51. Gerber SH, Rizo J, Sudhof TC, (2002) Role of electrostatic and hydrophobic interactions in Ca(2+)-dependent phospholipid binding by the C(2)A-domain from synaptotagmin I. Diabetes 51 (Suppl 1):: S12-S18.
52. Singh S, Khan AR, Gupta AK, (2012) Role of glutathione in cancer pathophysiology and therapeutic interventions. J Exp Ther Oncol 9: 303-316.
53. Backos DS, Franklin CC, Reigan P, (2012) The role of glutathione in brain tumor drug resistance. Biochem Pharmacol 83: 1005-1012.
54. De Palma AM, Heggermont W, Lanke K, Coutard B, Bergmann M, et al. (2008) The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C. J Virol 82: 4720-4730.
55. Wessels E, Duijsings D, Notebaart RA, Melchers WJ, van Kuppeveld FJ, (2005) A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J Virol 79: 5163-5173.
56. De Palma AM, Thibaut HJ, van der Linden L, Lanke K, Heggermont W, et al. (2009) Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother 53: 1850-1857.
57. Steurbaut S, Vrijsen R, (2003) The morphogenesis of Theiler's murine encephalomyelitis virus is strain specific. Arch Virol 148: 1135-1153.
58. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.